This role involves leading the design, development, and advancement of radiopharmaceutical programs to transform cancer treatment
Job Summary
This role involves leading the design, development, and advancement of radiopharmaceutical programs to transform cancer treatment.
The successful candidate will drive CMC process development, oversee IND-enabling activities, and manage technology transfers to internal and external manufacturing sites.
RayzeBio offers a dynamic environment blending biotech innovation with global resources, providing competitive compensation including health coverage and paid time off.
Matching Summary
This role involves leading the design, development, and advancement of radiopharmaceutical programs to transform cancer treatment.
Salary
Base: $131,028 - $158,775; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Health coverage, 401(k), flexible time off, and paid holidays
Skills & Requirements
Must-have
Radiochemical synthesis expertise
CMC process development for radiopharmaceuticals
Technology transfer to CDMO partners
Regulatory compliance for radioactive materials
Advanced analytical techniques in radiochemistry
Nice-to-have
Mentoring junior scientists
Experience with novel radioisotope development
Collaboration with academic partners
Innovation in radiopharmaceutical formulation
Strong project management skills
Key Requirements
PhD + 3 years or MSc + 6 years in Chemistry/Radiochemistry
Significant CMC work experience with radiopharmaceutical products
Proven track record in Phase 1 clinical program technology transfers
Deep familiarity with federal and state regulatory requirements for radioactive materials